Bringing the fundamentals into focus…
Back to YD Bio Ltd
How YD Bio Ltd stacks up
YDES · against 433 other Healthcare companies of similar size
Valuation
8/ 100
Near the bottom of its peers.
Ranked #275 of 434 · scores higher than 11% of peers
Bars: peers in each 10-point band of the valuation score160 peers with a valuation score of 0–9, including YDES · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its EBITDA yield, which is weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -1.2% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -1.8% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -1.8% vs peer median 0.0%
Metric by metric
Position: dot = YDES, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | YDES | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 420 reported | 0.0% | 0.3% | 48% | 30% | |
| EBITDA yieldHigher is better · 439 reported | -1.4% | 3.0% | 34% | 50% | |
| Free cash flow yieldHigher is better · 200 reported | Not reported | -7.7% | — | — | 20% |
| Book yieldHigher is better · 430 reported | 71.5% | 49.2% | 70% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by valuation score
Top 5 and the companies ranked around YDES| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 275 | 227M USD | 8 | 24 | |
| 275 | 885M USD | 8 | 33 | |
| 275 | 595M USD | 8 | 29 | |
| 275 | 705M USD | 8 | 32 | |
| 275 | 453M USD | 8 | 6 | |
| 275 | 382M USD | 8 | ||
| 387 | 1.9B CNY (≈$270M) | 7 | 17 | |
| 387 | 3.3B CNY (≈$458M) | 7 | 49 | |
| 387 | 4.1B CNY (≈$575M) | 7 | 34 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score